ZA200903094B - Compositions and multiplex assays for measuring biological mediators of physiological health - Google Patents
Compositions and multiplex assays for measuring biological mediators of physiological healthInfo
- Publication number
- ZA200903094B ZA200903094B ZA200903094A ZA200903094A ZA200903094B ZA 200903094 B ZA200903094 B ZA 200903094B ZA 200903094 A ZA200903094 A ZA 200903094A ZA 200903094 A ZA200903094 A ZA 200903094A ZA 200903094 B ZA200903094 B ZA 200903094B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- measuring biological
- multiplex assays
- physiological health
- biological mediators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84992806P | 2006-10-06 | 2006-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200903094B true ZA200903094B (en) | 2010-07-28 |
Family
ID=39364961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200903094A ZA200903094B (en) | 2006-10-06 | 2009-05-05 | Compositions and multiplex assays for measuring biological mediators of physiological health |
Country Status (11)
Country | Link |
---|---|
US (2) | US20100196880A1 (de) |
EP (1) | EP2069524A4 (de) |
JP (1) | JP2010505420A (de) |
CN (1) | CN101627129B (de) |
AU (1) | AU2007318208B2 (de) |
BR (1) | BRPI0717803A2 (de) |
CA (1) | CA2665164A1 (de) |
MX (1) | MX2009003583A (de) |
RU (1) | RU2520080C2 (de) |
WO (1) | WO2008057160A2 (de) |
ZA (1) | ZA200903094B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5656209B2 (ja) * | 2008-09-26 | 2015-01-21 | 独立行政法人産業技術総合研究所 | ウシタイレリア症の病態評価を可能とする方法 |
ES2677944T3 (es) | 2009-11-25 | 2018-08-07 | Hologic Inc. | Detección de infección intraamniótica |
CN103328653A (zh) * | 2010-11-24 | 2013-09-25 | 霍夫曼-拉罗奇有限公司 | 用于检测低度炎症的方法 |
WO2012129312A2 (en) * | 2011-03-21 | 2012-09-27 | Laboratory Corporation Of America Holdings | Methods and systems for multiple control validation |
CA2843473A1 (en) * | 2011-08-12 | 2013-02-21 | Alfred Health | Method for diagnosis, prognosis or treatment of acute coronary syndrome (acs) comprising measurement of plasma concentration of macrophage migration inhibitory factor (mif) |
CN102749448B (zh) * | 2012-07-27 | 2014-07-02 | 复旦大学附属中山医院 | 用于评估肺腺癌化疗效果的试剂盒 |
WO2014037811A2 (en) * | 2012-09-07 | 2014-03-13 | The Governors Of The University Of Alberta | Methods and compositions for diagnosis of inflammatory liver disease |
CN113156138A (zh) * | 2013-01-03 | 2021-07-23 | 梅索磅秤技术有限公司 | 测定实验对象组 |
JP5710666B2 (ja) * | 2013-02-25 | 2015-04-30 | 敦生 関山 | 生体負荷の指標剤および生体負荷の測定方法 |
JP6532456B2 (ja) | 2013-10-04 | 2019-06-19 | ライフ テクノロジーズ コーポレーション | 終止化学を用いる配列決定における整相効果(phasing effects)をモデル化するための方法及びシステム |
CN103837687A (zh) * | 2014-03-10 | 2014-06-04 | 青岛康立泰药业有限公司 | 使用具有白细胞介素-12受体的细胞检测重组人白细胞介素-12体外活性的方法及应用 |
US10435747B2 (en) * | 2014-08-19 | 2019-10-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Radiation biodosimetry systems |
BR112017005730B1 (pt) | 2014-09-26 | 2023-12-12 | Somalogic Operating Co., Inc | Método para triagem de um indivíduo quanto ao risco de um evento cardiovascular ou para predizer a probabilidade que um indivíduo tenha tal evento |
JP6959136B2 (ja) | 2015-01-23 | 2021-11-02 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 患者の示差的な栄養所要量の決定方法 |
ES2952744T3 (es) | 2016-12-15 | 2023-11-03 | Nestle Sa | Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía |
CN110325106A (zh) * | 2017-02-20 | 2019-10-11 | 加利福尼亚大学董事会 | 无症状性脑缺血的血清学测定 |
US11408885B2 (en) | 2017-08-31 | 2022-08-09 | Massachusetts Institute Of Technology | Compositions and multiplex assays for characterizing active proteases and their inhibitors |
CN112136048A (zh) * | 2018-02-21 | 2020-12-25 | 艾迪菲斯健康有限公司 | 测量全身性慢性炎性衰老的方法 |
RU2698092C1 (ru) * | 2018-04-10 | 2019-08-22 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт общей патологии и патофизиологии" | Способ выявления предрасположенности к заболеванию атеросклерозом на основе определения экспрессии генов, вовлеченных в накопление холестерина |
JP2022544169A (ja) | 2019-08-07 | 2022-10-17 | エディフィス・ヘルス・インコーポレイテッド | 心血管疾患の処置および予防 |
CN110850096B (zh) * | 2019-09-29 | 2023-02-17 | 瑞博奥(广州)生物科技股份有限公司 | 生物标记物组及其应用和蛋白芯片、蛋白芯片试剂盒和elisa试剂盒 |
JP2024504009A (ja) * | 2020-12-22 | 2024-01-30 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 間質性膀胱炎の評価および治療のための方法、キット、および組成物 |
CN114404601B (zh) * | 2022-03-31 | 2022-06-07 | 首都医科大学附属北京朝阳医院 | MDK抑制剂在制备用于抑制干扰素-γ治疗引起的肿瘤转移的药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE505391C2 (sv) * | 1995-05-30 | 1997-08-18 | Cortendo Ab | Användning av kortisol-agonister för framställning av ett system för diagnostisering av det metabola syndromet |
US20040225449A1 (en) * | 1999-06-28 | 2004-11-11 | Bevilacqua Michael P. | Systems and methods for characterizing a biological condition or agent using selected gene expression profiles |
US7465540B2 (en) * | 2000-09-21 | 2008-12-16 | Luminex Corporation | Multiple reporter read-out for bioassays |
US20040191775A1 (en) * | 2003-03-12 | 2004-09-30 | Spindler Stephen R. | Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics |
CA2574360A1 (en) * | 2004-07-19 | 2006-01-26 | N.V. Nutricia | A preparation for use of aspartate for regulating glucose levels in blood |
-
2007
- 2007-10-04 MX MX2009003583A patent/MX2009003583A/es active IP Right Grant
- 2007-10-04 BR BRPI0717803-4A patent/BRPI0717803A2/pt not_active IP Right Cessation
- 2007-10-04 CN CN200780037405.0A patent/CN101627129B/zh not_active Expired - Fee Related
- 2007-10-04 AU AU2007318208A patent/AU2007318208B2/en not_active Ceased
- 2007-10-04 JP JP2009531477A patent/JP2010505420A/ja active Pending
- 2007-10-04 EP EP07867209A patent/EP2069524A4/de not_active Withdrawn
- 2007-10-04 RU RU2009116433/10A patent/RU2520080C2/ru not_active IP Right Cessation
- 2007-10-04 US US12/311,542 patent/US20100196880A1/en not_active Abandoned
- 2007-10-04 CA CA002665164A patent/CA2665164A1/en not_active Abandoned
- 2007-10-04 WO PCT/US2007/021451 patent/WO2008057160A2/en active Application Filing
-
2009
- 2009-05-05 ZA ZA200903094A patent/ZA200903094B/xx unknown
-
2011
- 2011-11-15 US US13/296,751 patent/US20120122717A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2665164A1 (en) | 2008-05-15 |
MX2009003583A (es) | 2009-04-15 |
RU2520080C2 (ru) | 2014-06-20 |
CN101627129A (zh) | 2010-01-13 |
EP2069524A2 (de) | 2009-06-17 |
CN101627129B (zh) | 2014-07-02 |
JP2010505420A (ja) | 2010-02-25 |
US20100196880A1 (en) | 2010-08-05 |
WO2008057160A2 (en) | 2008-05-15 |
WO2008057160A3 (en) | 2009-05-14 |
EP2069524A4 (de) | 2010-02-24 |
RU2009116433A (ru) | 2010-11-20 |
AU2007318208A1 (en) | 2008-05-15 |
BRPI0717803A2 (pt) | 2013-11-19 |
AU2007318208B2 (en) | 2013-10-24 |
US20120122717A1 (en) | 2012-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200903094B (en) | Compositions and multiplex assays for measuring biological mediators of physiological health | |
HK1247531A1 (zh) | 人乳組合物 | |
EP2069768A4 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von typ-2-diabetes | |
EP1988824A4 (de) | Klinische anwendungen der sto2-analyse | |
EP2201370A4 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von typ-2-diabetes | |
GB0616376D0 (en) | Raman analysis of tissue | |
EP2046108A4 (de) | Veränderung der fettsäurezusammensetzung von reis | |
ZA201000095B (en) | Multiple analysis of blood samples | |
EP2005168A4 (de) | Verfahren und zusammensetzung zur diagnose von krankheiten der aorta | |
EP2063722A4 (de) | Verfahren zur herstellung von steriler milch und ihren zusammensetzungen | |
EP2034893A4 (de) | Messung der sauerstoffanreicherung von gewebe | |
PT2029220E (pt) | Sonda médica | |
EP1933883A4 (de) | Verfahren und zusammensetzungen zur diagnose von iga- und igm-vermittelten nierenerkrankungen | |
EP1986665A4 (de) | Aus mikroalgen stammende zusammensetzungen zur verbesserung der gesundheit und des erscheinungsbilds der haut | |
PL1993443T3 (pl) | Wskaźnik stanu zdrowia | |
GB2448746B (en) | Rheological measurement of filtercake | |
ZA200809200B (en) | Enumeration of thrombocytes | |
GB0522894D0 (en) | Application of biosensor chips | |
PL1816116T6 (pl) | Kompozycje chemiczne i sposoby ich wytwarzania | |
HK1148760A1 (en) | Compositions and methods for early pregnancy diagnosis | |
IL192319A0 (en) | Assessment of medical conditions | |
GB2451196B (en) | Compositions for healing of tissue of multicellular organisms | |
EP2061486A4 (de) | Verfahren und zusammensetzungen zum verschliessen und anheften von biologischem gewebe und medizinische anwendungen | |
EP2068902A4 (de) | Aus tee gewonnene zusammensetzung und verfahren zu ihrer verwendung für die behandlung des herzens | |
EP2147013A4 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von depressionen und angst |